AKT has recently been reported to be a critical regulator of CSC survival and maintenance of the CSC phenotype in breast cancer [75 Importantly, it was reported that the activation of the AKT and BCL-2 cell survival response in CSCs confer chemoresistance in HCC [10]. Here, BCL2 is linked to hepatocellular carcinoma.